A pilot study of a ketogenic diet in patients with Lafora body disease

Epilepsy Research
Simonetta CardinaliPierangelo Veggiotti

Abstract

Lafora body disease (LBD) is severe and rapidly worsening progressive myoclonus epilepsy (PME), not treatable with specific therapy. In LBD patients, typical polyglucosan accumulations result from alterations of proteins involved in the regulation of glycogen metabolism. Thus, a ketogenic regimen might reasonably be expected to counteract the disease progression. We set out to assess the feasibility and tolerability of a long-term ketogenic diet (KD) in LBD patients and to make a preliminary evaluation of its effect on the disease course. We treated five LBD patients with KD and evaluated the changes in the clinical, neuropsychological and neurophysiological findings over 10-30 months. The KD was well tolerated in all the patients for the first 16 months. Nutritional measures and laboratory findings remained substantially stable. The disease progressed in all the patients, reaching an advanced stage in one. Electrophysiological findings indicated the presence of increased cortical excitability in four patients, paralleling the worsening of the myoclonus. KD was unable to stop the disease progression. However, given the considerable heterogeneity of the natural history of LBD, we cannot exclude the possibility that KD has the po...Continue Reading

References

Sep 6, 2003·Nature Genetics·Elayne M ChanStephen W Scherer
Feb 1, 2005·Epilepsia·Eric H Kossoff, Jane R McGrogan
Mar 15, 2006·Epilepsia·Silvana FranceschettiFederico Zara

❮ Previous
Next ❯

Citations

Jun 10, 2010·CNS Drugs·Thomas S Monaghan, Norman Delanty
Jun 17, 2009·Expert Opinion on Pharmacotherapy·Danielle M AndradeBerge A Minassian
Apr 16, 2013·Annales de pathologie·Héla MnifTahya Sellami Boudawara
Oct 4, 2011·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·A VerrottiG Gobbi
Aug 30, 2011·Epilepsy Research·Adam L Hartman
Jun 12, 2009·Brain & Development·Pierangelo VeggiottiUmberto Balottin
Nov 26, 2008·Revue neurologique·N PortaS Auvin
Feb 17, 2007·Revue neurologique·P Genton
Dec 8, 2007·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Anna PichiecchioCarla Uggetti
Jan 24, 2007·Epilepsia·Adam L Hartman, Eileen P G Vining
Oct 2, 2014·Epilepsia·Edoardo FerlazzoUmberto Aguglia
Jul 19, 2011·Seizure : the Journal of the British Epilepsy Association·Roberto CaraballoLuis Paníco
Sep 3, 2016·European Journal of Pediatrics·Ludovica PascaPierangelo Veggiotti
Oct 27, 2016·The Journal of Small Animal Practice·I HajekV Palus
Mar 2, 2012·Journal of Child Neurology·Radhika DhamijaElaine C Wirrell
Aug 3, 2017·PloS One·Lindsay SwainClare Rusbridge
Nov 22, 2011·Neurologia i neurochirurgia polska·Sergiusz JóźwiakKatarzyna Kotulska-Jóźwiak
Mar 11, 2020·Expert Review of Neurotherapeutics·Antonella RivaPasquale Striano
Aug 26, 2018·Nature Reviews. Neurology·Felix NitschkeBerge A Minassian
Dec 17, 2020·Neurology. Genetics·Lori IsraelianBerge A Minassian
Dec 6, 2020·Neurology·Priya PurushothamanTracy S Gertler
Aug 7, 2021·Life·Thilo von KlopmannClare Rusbridge
Aug 18, 2021·Orphanet Journal of Rare Diseases·Federica PondrelliFrancesca Bisulli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.